Five targets for investors’ health and wellness dollars.
Don’t let robust sales fool you: The short-term “buzz” of Red Bull and its clones is losing appeal among consumers and investors. Lately, notes Ferrier, the money is on “natural alternatives for boosting energy and alternatives to caffeine.” Take proteins, for example-especially those from vegetarian and “natural” sources. The macronutrient, Ferrier notes “was at the heart of some significant deals in 2014,” including Hormel Foods’ acquisition of Muscle Milk, and Glanbia’s purchase of Isopure protein drinks and powders.
<<Previous Next>>
Photo © iStockphoto.com/deymos
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
The 2023 Supplement Consumer: Immune Health and Beyond
April 19th 2024Did you know two-out-of-three U.S. supplement consumers say their immune health has become more important to them, yet only 38% would describe their immune health as “very healthy?” There’s an opportunity to meet consumers in their growing desire to live healthier lifestyles and help them redefine resilience. IMMUSETM is the universal postbiotic for year-round immune support. Unlock exclusive consumer insights and discover the formulation opportunities with IMMUSETM with this consumer research.